Newsbot Nachrichten

Will Accelerating AWS Revenue Growth Drive AMZN Stocks 2026 Rally?

Amazons AWS posts its fastest growth since 2022 as AI demand surges, with a $200 billion backlog and heavy investment fueling 2026 optimism.

Kratos Defense Stock Rises 35.3% in a Month: Heres How to Play

KTOS has jumped 35.3% in a month on contract wins and rising unmanned system demand, but weaker ROIC and sector risks complicate the entry timing.

3 Medical Service Industry Stocks Set to Tackle Workforce Challenges

Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.

Salesforce Plunges 20% in a Year: Is the CRM Stock Still a Hold?

CRM shares are down 18% in a year, but AI momentum, enterprise expansion and discounted valuation suggest Salesforce may still be worth holding.

JPM Q4 Earnings on Deck: Buy, Sell or Hold the Stock Ahead of Results?

JPMorgans Q4 earnings preview shows strength in trading and lending, but expenses and valuation may weigh on investor sentiment.

BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock?

BMY shares have surged in the past six months, driven by Opdivo, Reblozyl and a guidance raise, as growth drugs offset mounting generic pressure

XOMs Integrated Business Model Shields Earnings Amid Lower Oil Prices

ExxonMobil warns that upstream earnings face pressure from lower oil prices, but its integrated model boosts refining gains to cushion profitability.

HELE Q3 Earnings Meet Estimates, Home & Outdoor Sales Decline Y/Y

HELEs third-quarter earnings meet estimates as sales decline year over year, with Home & Outdoor weakness partly offset by Olive & June growth.

Goldman Projects 46-Cent EPS Gain in Q4 From Apple Card Transition

GS expects a 46-cent EPS boost in 4Q25 as it exits the Apple Card, releasing reserves amid a 24-month transition of the program to JPMorgan.

3 MedTech Stocks That Crushed the S&P 500 Over the Past Year

TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.

New Strong Buy Stocks for January 9th

BDTX, LUMN, ADEA, ACRE and TACT have been added to the Zacks Rank #1 (Strong Buy) List on January 9th, 2026.

Heres What We Expect From AbbVies Immunology Segment in Q4

ABBVs Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humiras past loss of exclusivity.

3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns in 2026

Broker upgrades make TripAdvisor, Marathon Petroleum and J.B. Hunt Transport top picks for 2026, with strong earnings growth on the horizon.

Salesforce Plunges 20% in a Year: Is CRM Stock Still a Hold?

CRM shares are down 18% in a year, but AI momentum, enterprise expansion and discounted valuation suggest Salesforce may still be worth holding.

Best Growth Stocks to Buy for January 9th

CIEN and CMC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 9th, 2026.

Enterprise Products Up 6% in a Year: Time to Bet on the Stock or Wait?

EPD beat its industry with a 6% yearly gain, backed by inflation-linked contracts and capital returns, but valuation and leverage argue for patience.

The S&P 500 Is Expected to Rally 12% This Year

Goldman Sachs Research predicts US stocks will rally again in 2026 amid solid economic growth and continued easing from the Fed.

UBER vs. BIDU: Which Stock Is Better Placed in the Promising AV Space?

Baidu edges ahead of Uber in the AV race, backed by global robotaxi rollout, stronger earnings outlook and valuation.

Best Income Stocks to Buy for January 9th

ACRE, STEP and ADEA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 9th, 2026.

SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales

Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support confidence for the rest of fiscal 2026.

Merck in Talks to Buy Revolution Medicines Per Financial Times Report

Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.

The Stock-Market Rally Isn’t Just About Tech Anymore

Hopes for an economic reacceleration are helping to fuel a “rotation trade.”

Oil Services ETF (OIH) Hits New 52-Week High

OIH hits a fresh 52-week high as oil prices stay firm and momentum builds. Can the rally last amid high risk?

Looking for a Growth Stock? 3 Reasons Why Commercial Metals (CMC) is a Solid Choice

Commercial Metals (CMC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Where to Find Opportunities in AI Stocks at the Start of 2026

AI stocks flew high in 2025 despite year-end volatility. Palantir and Lam look overvalued, but opportunities remain.

Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond

After a late-2025 rebound eased policy fears, healthcare ETFs like IXJ are gaining attention as investors position for a sector comeback in 2026.

Verizon Outpaces Its Industry in a Year: How to Play the Stock?

VZ has outpaced its wireless industry over the past year as 5G upgrades, network slicing and new partnerships fuel growth despite debt and competition.

Ondas Up Nearly 600% in the Past Six Months: How to Play the Stock?

ONDS has surged nearly 600% in six months as it pivots to autonomous systems, but soaring costs and valuation raise exit questions.

ADI Climbs 35.7% in a Year: Should You Buy, Sell or Hold the Stock?

Analog Devices shares surge 35.7% in a year as AI-driven demand lifts industrial and communications growth, boosts data center sales and supports strong margins.

Best Value Stocks to Buy for January 9th

ACRE made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 9th, 2026.

3 Construction & Mining Equipment Stocks to Watch Despite Industry Headwinds

The Zacks Industry Rank for the Manufacturing - Construction and Mining industry paints a dull picture. We believe that stocks like CAT, TEX and ASTE are still worth a look.

4 Top-Ranked Tech Stocks to Buy as Semiconductor Rally Continues

Semiconductor sales hit a record in November, with NVDA, MU, CRDO and ASYS set to gain from booming AI demand.

Gold Steadies as Mixed US Data Dims Fed Rate-Cut Bets This Month

Gold steadied as traders maintained expectations that the Federal Reserve will hold rates steady at their January meeting, after key US jobs data gave mixed signals about the health of the US economy.

NASA to bring Space Station astronauts back to Earth weeks early due to medical situation

NASA earlier delayed a planned spacewalk with ISS Commander Mike Fincke and flight engineer Zena Cardman.

Lumos Diagnostics Holdings Limited (LDXHF) Shareholder/Analyst Call Transcript

Trump Has ‘No Plan’ For Venezuela After Maduros Capture: Debbie Wasserman Schultz

Rep. Debbie Wasserman Schultz (D-FL) joined "Forbes Newsroom" to discuss whats next following the capture of Venezuelan President Nicolás Maduro by U.S. forces.

Why Tilray Brands Stock Is Rising in After-Hours Trading

Tilray had good things to say about its recent quarter -- and investors were listening.

Job Openings Fall To 14-Month Low

Booz Allen Hamilton: A Much More Constructive Environment In 2026

Jim Cramer says the market rotation is punishing last year’s winners and reviving beaten-down stocks

Jim Cramer said investors are witnessing a classic market rotation, as capital flows from last year’s biggest winners into stocks that had fallen out of favor.

3 Millionaire-Maker Artificial Intelligence (AI) Stocks

You dont have to buy risky stocks to invest in the AI boom.

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M

Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility

Ukraine Awards Major Lithium Project to Investors With Links to Trump

Ronald S. Lauder, a billionaire friend of Mr. Trump, is among the investors. The move comes as the Trump administration looks to profit from investment opportunities in Ukraine.

Wall Street strategist reveals game plan for 2026

Sam Stovall has been navigating stocks for a long time. Stovall is the Chief Investment Strategist at CFRA, and his stock market experience is rooted in over 30 years of tracking markets, dating back to his tenure as managing director and chief investment strategist at S&P Global and ...

IRW-News: Lir Life Sciences Corp.: LIR Life engagiert Neuland Labs, um die Entwicklung zelldurchdringender Peptide für die transdermale GLP-1/GIP-Plattform voranzutreiben

IRW-PRESS: Lir Life Sciences Corp.: LIR Life engagiert Neuland Labs, um die Entwicklung zelldurchdringender Peptide für die transdermale GLP-1/GIP-Plattform voranzutreibenVancouver, Kanada - 8. Januar 2026 / IRW-Press / LIR Life Sciences Corp. (CSE: ...